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Abstract We assessed predictors of choosing self-admin-
istered oral HIV testing in the clinic with supervision
versus the standard provider-administered blood test when
offered the choice among 149 Kenyan truck drivers,
described the types of guidance participants needed during
self-testing and predictors of needing guidance. Overall,
56.38% of participants chose the self-test, 23.49% the
provider-administered test, and 20.13% refused testing. In
the adjusted regression models, each additional unit on the
fatalism and self-efficacy scales was associated with 0.97
(p = 0.003) and 0.83 (p = 0.008) times lower odds of
choosing the self-test, respectively. Overall, 52.38% of
self-testers did so correctly without questions, 47.61%
asked questions, and 13.10% required unsolicited correc-
tion from the provider. Each additional unit on the fatalism
scale was associated with 1.07 times higher odds of asking
for guidance when self-testing (p\ 0.001). Self-adminis-
tered oral HIV testing seems to be acceptable and feasible
among Kenyan truck drivers, especially if given the
opportunity to ask questions.
Resumen Evaluamos los factores predictores de elegir de
la prueba oral de VIH autoadministrada en la clı´nica con
supervisio´n versus la prueba esta´ndar de sangre adminis-
trada por el proveedor cuando se les ofrecio´ la eleccio´n
entre 149 conductores de camiones en Kenia; tambie´n
describimos la ayuda que los participantes necesitaron
durante la autoadministracio´n y predictores de necesitar
ayuda. En total, el 56,38% de los participantes opto´ por la
prueba autoadministrada, el 23,49% opto´ por la prueba
administrada por el proveedor, y 20,13% rehuso´ hacer la
prueba. En los modelos de regresio´n ajustados, cada unidad
adicional en las escalas de fatalismo y autoeficacia se
asocio´ con 0,97 (p = 0,003) y 0,83 (p = 0,008) veces
menos Probabilidad de elegir la prueba autoadministrada,
respectivamente. En total, el 52,38% de los participantes
autoadministradores hizo la prueba correctamente sin tener
preguntas, el 47,61% hizo preguntas y el 13,10% necesi-
taba correccio´n por el proveedor no solicitada por parte del
participante. Cada unidad adicional en la escala de fata-
lismo se asocio´ con 1,07 veces mayores probabilidad de
hacer preguntas entre los participantes autoadministradores
(p\ 0,001). La prueba oral de VIH autoadministrada
parece ser aceptable y factible entre los conductores de
camiones en Kenia, especialmente si se les da la oportu-
nidad de hacer preguntas.
Keywords Diagnostic tests  HIV  HIV testing  Kenya
Introduction
In 2014, the Joint United Nations Programme on HIV and
AIDS (UNAIDS) launched its ambitious 90-90-90 HIV
testing and treatment goals that by 2020, 90% of people
living with HIV will know their HIV status, 90% of people
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diagnosed with HIV will receive sustained antiretroviral
therapy, and 90% of people receiving antiretroviral therapy
will have viral suppression [1]. A key motivation for these
goals is the finding that treatment as prevention is effective
in decreasing HIV incidence [2], and the World Health
Organization (WHO) has recommended that all people
living with HIV, regardless of CD4? T cell count, should
initiate treatment immediately for improved health and to
decrease the probability of transmission to others [3].
However, HIV testing rates in many countries remain
suboptimal, and in Kenya 2012–2013, only a little over half
of those age 15–64 had tested in the past year and 53% of
those HIV-infected were unaware of their HIV status [4].
New HIV testing strategies will likely be needed in order to
reach the 90-90-90 goals
Truck drivers in Africa have been characterized as a key
population to target for HIV prevention, testing and treat-
ment services due to their high HIV risk and unmet need
for services [5–7], and because they can be a conduit for
the spread of HIV between female sex workers (FSWs) and
other partners and across international borders due to work-
related travel [6, 8]. Health clinics targeting truck drivers
now appear along many major trucking routes [9–11], but
the few available studies suggest that testing uptake in this
population remains low. A 2003–2004 survey of 1896
long-distance truck drivers in South Africa found that only
38.2% had ever been tested for HIV [12]. In a 2009 study
in a night clinic at a truck stop in northern Mozambique,
only a quarter of participants accepted HIV testing when
offered and, of those, 27% tested HIV? [10]. A 2010 study
among long distance truck drivers in Togo found 47.4%
had ever tested for HIV [13]. In 2012, the North Star
Alliance, an organization that runs 35 roadside wellness
clinics providing services to truck drivers on major transit
routes in Africa, reported only about 21% of 219,681 cli-
ent-visits included HIV testing despite the fact that testing
is offered at every visit [14]. Trucking Wellness, which
runs 22 roadside clinics for truck drivers in South Africa,
reported that only about 10% of the[90,000 clients seen in
2012 were tested for HIV, of which 7% were found to be
HIV? [15]. Thus, despite the convenience of roadside
health facilities, demand for HIV testing remains low,
suggesting that barriers persist.
On July 3, 2012, the United States (US) Food and Drug
Administration (FDA) approved a rapid self-administered
oral HIV test for at-home use (OraQuick In-Home HIV
Test) [16]. This test can be used in or outside of a clinic
setting, and has the potential to reduce a number of barriers
to HIV testing faced by truck drivers, therefore potentially
providing a more acceptable option for people in mobile
professions who do not use existing HIV testing and
counseling services. The ability to self-test at home or in
private may allay concerns about the stigma of being seen
at the clinic and possible breach of confidentiality, barriers
often cited [17–20]. Self-administered testing in a clinic
setting may also reduce the burden on healthcare staff,
since staff is no longer performing the test, and thus shorten
clinic waiting time; for those using the test outside of a
clinic setting, there may be the added benefit of reduced
travel and wait time and cost, although travel may be
required to obtain the test kit. Furthermore, if the HIV test
can be used outside of the clinic, truck drivers could pick
up a test kit at a roadside clinic and test at home, which
may be a less stressful environment [19, 21] and where
they have access to their network of family and friends
should they choose to test with a partner and/or discuss
their testing experience and results with someone they
trust.
Numerous studies have found self-administered HIV
testing to be acceptable in African populations [22–29]. If
this test will appeal to those at highest risk or those not
testing under current testing programs, it has a great
potential to increase testing rates. On the other hand,
making such a test available might result in migration of
those already testing to this new testing modality which
might be less accurate than provider-administered testing
when administered by someone with no training [30].
While there has been concern about migration from one
HIV prevention method (condoms) to another (microbi-
cides, medical male circumcision), there is limited evi-
dence that such migration has or will occur [31]. Whether
migration will be an issue for different testing modalities is
unknown. Error rates in self-testing among African popu-
lations may also be a concern. In one study among South
African healthcare workers, three of nine participants who
self-tested HIV-positive incorrectly interpreted their tests
as negative, resulting in a user sensitivity of only 66.7%,
but 100% specificity. However, the authors argued that this
could be improved with better instructions [27]. In another
study among participants recruited from healthcare and
workplace facilities in Kenya, the sensitivity of self-ad-
ministration of the test was 89.5% and the specificity
99.4% when compared with a provider-administered rapid
blood (finger-prick) test as the ‘‘gold standard’’ [23, 24]. A
third study among a representative sample of suburban
residents of Malawi found a sensitivity of 97.9% and
specificity of 100% when compared with a provider-ad-
ministered blood-based (finger-prick) test as the standard
[26]. Ensuring support for confirmatory testing and linkage
to HIV care for those who self-test HIV? is another con-
cern [30].
Whether truck drivers with certain demographic char-
acteristics, or those at highest risk and/or not currently
testing would prefer self-testing to provider-administered
testing and whether they are able to administer the test and
interpret the results correctly is unknown. In addition, it
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could be that truck drivers with certain psychosocial
characteristics differ in the benefit they see to HIV testing
in general or self-testing specifically, or in whether the
offer of self-testing works as a cue to action (HIV test
acceptance), two factors suggested by the Health Belief
Model as impacting whether or not someone seeks
screening [32]. Fatalism [33], anticipated HIV stigma [34]
and low self-efficacy [35] have all been associated with
decreased HIV testing in various populations, while low
gender-equitable norms [36, 37] and sensation-seeking
[38, 39] have been associated with increased HIV risk
behavior in other groups.
Therefore, this paper explores potential predictors (de-
mographic characteristics, HIV-related behavior, and
scores on various psychosocial scales) of choosing a self-
administered oral rapid HIV testing in the clinic with
provider supervision versus the standard provider-admin-
istered blood-based (finger prick) rapid test among a
sample of Kenyan truck drivers. We also describe whether
the truck drivers were able to administer the test and
interpret the results by themselves and the steps in the self-
testing process where they sought or required guidance
from the provider in order to administer the test correctly.
In addition, we look at predictors of needing guidance
when self-administering the oral HIV test.
Methods
Study Participants
We explored these secondary research questions using data
from a randomized controlled trial evaluating if offering
choices in HIV testing (provider-administered blood-based
(finger prick) rapid HIV test or oral self-administered rapid
HIV testing in the clinic with supervision or, only for those
who refused both in-clinic testing options, a test kit for
home use) versus the standard care (only offering the
provider-administered blood test) would increase HIV
testing uptake among truck drivers in Kenya. Participants
were recruited from two North Star Alliance roadside
wellness clinics located in Nakuru county, which has
among the highest HIV prevalence in the country [40, 41].
The clinics provide primary healthcare services to key
populations in Africa, such as truck drivers and sex
workers, including HIV screening and treatment [9, 42].
Any male truck driver or trucking assistant (both referred
to as truck drivers here) who visited the two clinics from
October 2015 to December 2015 for services other than
HIV treatment were informed by the receptionist that a
research study was being conducted and were referred to
one of the fieldworkers if interested for information and to
be screened for eligibility. Eligibility criteria were: (1) at
least 18 years old, (2) male (based on observation), (3)
employed as a truck driver, (4) primary residence in Kenya,
(5) able to speak English or Kiswahili, (6) self-reported
HIV-negative or unknown HIV status (7) able to sign the
consent form, and (8) willing to receive payment for par-
ticipation fees via MPesa (a cell phone-based money
transfer system widely used in Kenya). The study was
described to potential participants as being about HIV
testing experiences and preferences and they were told that
HIV testing would be offered, as it would be at any North
Star Alliance clinic visit, but their decision about testing
would not impact healthcare services or study eligibility.
Participants were not informed about the specific research
question or the fact that they would be randomized to
different HIV testing options in order to avoid bias.
Truck drivers who met eligibility criteria and consented
to participate had the baseline questionnaire administered
to them by the fieldworker, after which they were offered
HIV testing, with the test offered depending on the study
arm to which they were randomized. Those in the testing
choice arm were given a brief demonstration of the self-
testing kit before being asked to make their choice. Those
who selected the self-administered oral rapid HIV test in
the clinic had an HIV testing counselor (HTC) sit in the
room while the participant self-administered the test. The
participant was told he could ask questions and, if he did
something incorrectly, the provider intervened with unso-
licited instructions to ensure correct use of the test. The
participant was also told that he could either view the test
results with the HTC or alone in order to keep his test
results completely private if he chose. Those who viewed
the test results alone were encouraged to disclose the test
results to the counsellor (who was, in most cases, the same
person who supervised the testing) during posttest coun-
seling to better tailor the counseling and referrals given, but
if they chose not to disclose they were given posttest
counseling and referrals for both an HIV? and HIV- test
result. Those who refused both in-clinic testing options
were offered a test kit for home use with phone-based
posttest counseling.
The study procedures were approved by the City
University of New York Institutional Review Board, the
Kenya Medical Research Institute Ethics Committee, and
the University of KwaZulu-Natal Biomedical Research
Ethics Committee.
The baseline interview included questions on demo-
graphics, HIV testing history and risk behavior. In addition,
the questionnaire included a number of psychosocial scales
on anticipated HIV stigma, fatalism, gender-equity, general
self-efficacy and sensation-seeking (described below). All
interviews were conducted in Kiswahili, English, or both,
depending on the participant’s preference. The English
version of the questionnaire was translated into Kiswahili
582 AIDS Behav (2018) 22:580–592
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and back-translated from Kiswahili into English to ensure
accuracy of the translation. The HTC who supervised those
who chose to self-test completed a form noting the steps in
the process where the participant asked questions or where
they had to intervene to ensure the test was administered
correctly. Specifically, at each step in the testing process
the HTC noted if the participant (1) did the step correctly
without questions or correction, (2) did the step correctly
but asked questions, (3) did the step correctly but only after
unsolicited instruction from the counselor, or (4) did not do
the step correctly despite instruction. The HTC also noted
whether the participant asked to view the test result alone
or with the HTC and, if alone, whether the participant
disclosed the test results during posttest counseling.
Measures
Demographic Characteristics
We looked at a number of demographic characteristics. All
participants were male and of African race, and therefore
these variables were not included in the analysis. Age was
collected and examined in years. Marital status was
examined as an indicator for married (legal or common-
law) versus not. Education was examined as an indicator
for having completed at least high school (versus less than
high school completion). Income from truck driver job was
originally collected by asking ‘‘about how much money do
you earn on an average month driving a truck?’’ and those
who were unable or unwilling to specify their income were
then asked, ‘‘could you tell me if your income is less than
8000 Kenyan Shillings (KES), 8000–16,000,
16,001–24,000, 24,001–50,000, or[50,001 KES?’’ The
variable was dichotomized at about the first quartile into
mid-high income (24,000–55,000 KES, as 55,000 KES was
the highest income reported, which is about $235–$550 US
dollars) versus less.
HIV-Related Behaviors
We looked at a number of HIV-related behaviors. We
included an indicator for having regular partners along the
participant’s usual trucking route (road wives). We
explained what we meant by saying ‘‘Men who travel for
work often develop long-term romantic relationships with
women or men in the towns through which they travel. By
romantic relations I mean romantic attachments that may
include vaginal or anal sex or other sexual behaviors such
as oral sex or mutual masturbation. Do you have any reg-
ular partners, men or women with whom you have
romantic relations, other than a wife or main partner at
home, who you see on a regular basis, such as when
traveling through their town on your regular route?’’ We
also examined whether the participant had paid for sex in
the past 6 months, and whether the participant had always
used condoms when having sex during the past 6 months.
Only five participants reported not having been sexually
active in the past 6 months and those were coded into the
no risk group (i.e. no partners along the trucking route, had
not paid for sex in the past 6 months, and had always used
condoms when having sex during the past 6 months).
Alcohol consumption was examined based on response to
the question ‘‘In the past year, how often have you had a
drink containing alcohol?’’ Responses were dichotomized
into an indicator for any alcohol consumed (versus none),
which split the participants about in half. We also asked
about HIV testing history and years since last tested, with
those who had never tested having their age assigned to this
variable (i.e. the years since last test was coded as their age
since they had never tested).
Scales
We looked at five different psychosocial measures.
1) Anticipated HIV stigma: We used a nine-item
anticipated HIV stigma scale that was adapted from
the UNAIDS general population survey and the
Department of Health Services AIDS module, and
previously used in Botswana [43]. The scale presents
statements about possible stigma-related scenarios if
the participant was to test positive for HIV and others
found out about his status (e.g., Do you think you
would be treated badly by health workers?). Each
item elicited a yes/no response, and the number of
yes responses were summed for a possible score
range of 0–9, with higher scores indicating more
anticipated stigma. We allowed one missing response
on this scale (three participants were missing one
item) in calculating the summary score. The Cron-
bach’s alpha for the scale in this study was 0.80,
indicating good internal consistency.
2) General self-efficacy: We used a ten-item general
self-efficacy scale [44], with previous multicultural
validation in Europe and Asia [45], which presented
statements related to belief in one’s ability to cope
with a broad range of stressful or challenging
demands (e.g., I can always manage to solve difficult
problems if I try hard enough). Response options
were on a four-point Likert scale from ‘not at all
true’ to ‘exactly true.’ Responses were summed for a
possible score range of 10–40, with higher scores
indicating greater self-efficacy. We allowed for one
missing item in calculating the summary score (one
person was missing one item). Cronbach’s alpha for
AIDS Behav (2018) 22:580–592 583
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the scale in this study was 0.90, indicating good to
excellent internal consistency.
3) Fatalism: We used a 20-item fatalism scale [46] that
elicited agreement to a series of fatalistic statements
mostly related to health (e.g., If someone is meant to
get a serious disease, it doesn’t matter what kinds of
food they eat, they will get that disease anyway).
Response options were in a five-point Likert scale
ranging from ‘strongly disagree’ to ‘strongly agree.’
Responses were summed for a possible score range
of 20–100, with higher scores indicating greater
fatalistic views. Six participants were missing
responses to one or two items on the scale and we
allowed for two missing responses in calculating the
summary score. The Cronbach’s alpha for the scale
in this study was 0.94, indicating excellent internal
consistency.
4) Gender-equity: We used a 24-item gender-equity
scale (the Gender-Equitable Men scale [47]) that has
been widely used in sub-Saharan Africa [48]. It
consists of a series of statements related to relation-
ships between men and women (e.g., There are times
a woman deserves to be beaten) with response
options in the form of a three-point Likert scale
including ‘agree’, ‘partially agree’ and ‘do not
agree.’ Responses were summed for a possible score
range of 24–72, with higher scores indicating more
gender-equitable attitudes. Eleven participants were
missing responses to one or two items on the scale
and we allowed up to two items to be missing in
calculating the summary score. Cronbach’s alpha for
the scale in this study was 0.88, indicating good to
excellent internal consistency.
5) Sensation-seeking: We used a five-item sensation-
seeking scale [49], previously adapted for use in
South Africa [38, 39], with statements about self-
perceived propensity for risk and pleasure-seeking
(e.g., I would enjoy the feeling of jumping off a high
cliff into a river below). Responses were elicited on a
four-point Likert scale ranging from ‘not at all like
me’ to ‘very much like me,’ with a possible score
range of 5–20, with higher score indicating greater
sensation-seeking. There were no missing items on
the scale for any participants. Cronbach’s alpha for
the scale in this study was 0.74 after dropping the
first item to increase internal consistency.
Statistical analysis
Because the aims of this paper are to identify predictors of
the HIV test chosen when given a choice and describe the
self-testing process, in this paper we only used data from
those in the study who were offered HIV testing choices
(i.e., those randomized to the choice arm who received the
intervention to which they were randomized, n = 149; one
person in the choice arm was excluded because he was not
offered a choice of tests as per protocol based on his ran-
domization assignment). Because we are only looking at
acceptance of HIV testing in the clinic, those who refused
HIV testing in the clinic but later took a test kit for home
use were classified as in-clinic test refusers in this analysis.
We described the sample overall and by HIV test
selected for in-clinic use (i.e., no test, provider-adminis-
tered blood test, supervised self-administered oral test). To
assess the significance of differences by HIV test selected
we used a Pearson’s Chi square test for categorical vari-
ables (Fisher’s exact test for any variables with expected
cell counts\5) and the Kruskal–Wallis test for numeric
variables. We then used logistic regression to identify
predictors of choosing the supervised self-administered
oral test over the provider-administered blood test among
those who tested, conducting crude models looking at each
independent variable alone, a full multivariate model with
all the predictors included and, out of concern about the
number of variables examined and possible type 2 error, we
also conducted backward stepwise regression using p\ 0.2
as the cut-off for inclusion in the final model. We described
the self-administration of the oral HIV test among those
who chose that test, including the steps in the process
where the participants needed guidance, either by asking
questions or requiring unsolicited instruction from the
provider in order to administer the test correctly. Finally,
we used logistic regression to identify predictors of need-
ing guidance when self-testing among those who self-tes-
ted, following the same procedure described above to look
at associations in the crude, full multivariate, and final
backward stepwise models. All analyses were conducted in
SPSS version 23 (Chicago, IL) unless otherwise specified
in the tables, with p-values\0.05 considered statistically
significant and p-values between 0.05 and 0.15 considered
borderline significant.
Results
Description of the Sample
A total of 149 study participants were offered HIV testing
choices. Mean age was 37.07 years and 38.26% had
completed high school. Three-fourths of the participant
earned between 24,000 and 55,000 Kenyan Shillings per
month from their truck driving job, on average (about
$240–$550 US) and 82.99% were married. Almost half
(48.30%) of participants had regular partners on their
trucking route in addition to their wives or main partners at
584 AIDS Behav (2018) 22:580–592
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home, 52.86% had paid for sex in the past 6 months and
only 15.26% reported they had always used condoms
during sex in the past 6 months. Half of participants
(51.68%) reported drinking alcohol during the past year.
Only 10.07% reported never having been tested for HIV
and the mean years since last HIV test was 4.74. Partici-
pants had a low anticipated HIV stigma score, with a mean
of 0.80 and median of 0.00 on a scale of 0–9. Their mean
score on the fatalism scale was on the lower-mid range at
46.62 on a scale of 20–100, as were their scores on the
gender-equity and sensation-seeking scales (mean = 58.36
with a possible range of 24–72 and mean of 1.38 with a
possible range of 4–16, respectively). Participants scored
high on the general efficacy scale, with a mean of 36.64 out
of a possible range of 10–40. (Table 1).
Of the 149 participants, 20.13% refused HIV testing in
the clinic, 23.49% chose the provider-administered blood
test and 56.38% chose the self-administered oral test. There
were no significant differences in test selected by any
demographic variables. Among the HIV-related behaviors,
only alcohol consumption in the past year was significantly
associated with test selection. Specifically, those who had
not consumed any alcohol in the past year were more likely
to refuse testing (25.00 vs. 15.59% among those who
consumed alcohol) or to select the provider-administered
HIV test (29.17 vs. 18.18%) while those who reported
drinking alcohol were more likely to choose the self-ad-
ministered test (66.23 vs. 45.83%, p = 0.043). None of the
attitudinal or belief scales were significantly associated
with test selected, although the fatalism and gender-equity
scales were of borderline significance. The mean score on
the fatalism scale was higher among those who chose the
provider-administered test compared with the self-admin-
istered test or no test (54.57, 44.18 and 44.17, respectively,
p = 0.052); and the mean score on the gender-equity scale
was lower among those who chose the provider-adminis-
tered test compared to the self-administered test and no test
(56.20, 58.45, and 60.60, respectively, p = 0.089).
(Table 1).
Regression Model Results Looking at Predictors
of Choosing Supervised Self-administered Oral HIV
Testing
In the crude models among those who tested in the clinic,
which test was selected was significantly associated with
alcohol consumption and fatalism scale score. Those who
had consumed alcohol in the past year had odds of
choosing the self-administered test over the provider-ad-
ministered test 2.32 (95% CI: 1.04–5.19) times that of
those who had not consumed alcohol in the past year; and
for each additional unit on the fatalism scale score, the
odds of choosing the self-administered test were 0.98 (95%
CI: 0.96–0.99) times lower. Consistent condom use and
higher general self-efficacy scale scores were both associ-
ated with lower odds of selecting the self-administered test
but the associations were only of borderline significance
(OR = 0.44, 95% CI: 0.16–1.24 and OR = 0.93, 95% CI:
0.84–1.02). In the multivariate model with all variables
included, only scores on the fatalism, general self-efficacy
scales and consistent condom use were significantly asso-
ciated with selecting the self-administered test over the
provider-administered test (OR = 0.96, 95% CI:
0.93–0.99; OR = 0.86, 95% CI: 0.73–1.03; OR = 0.16,
95% CI: 0.02–1.42). In the backwards stepwise regression
model, only fatalism score, general self-efficacy score and
consistent condom use remained in the final model
(OR = 0.97, 0.94–0.99; OR = 0.83, 95% CI: 0.73–0.95;
and OR = 0.34, 95% CI: 0.10–1.14, respectively).
(Table 2).
Description of the Self-testing Procedures
Based on the observation checklist completed by the pro-
viders supervising the 84 participants who chose to self-
administer the oral HIV test, more than half of participants
(52.38%) completed the self-testing process without
needing any guidance, while 47.61% asked questions
during the self-testing and 13.10% needed the provider to
intervene with correction because they were doing some-
thing incorrectly and did not ask for instruction. Steps
where participants were more likely to need unsolicited
correction included waiting for the full 20 min before
reading the test result (6.17%) and interpreting the test
result (5.00%). All of the tests were HIV-negative. At each
step, about 20–30% of participants asked questions, with
more asking questions about how to open the package and
remove the materials (30.86%), locate and remove the
testing swab without touching it (30.77%), waiting 20 min
before viewing the test result (30.87%), and interpreting
the test result (30.00%). (Table 3) Nearly all participants
(97.40%) asked the provider to stay and view their test
results with them, while a few (2.60%) viewed the results
themselves but then disclosed the result during posttest
counseling. (Data not shown).
Regression Model Results Looking at Predictors
of Needing Guidance When Self-administering
the Oral HIV Test
In the crude models, those with higher anticipated stigma
and higher fatalism scores were significantly more likely to
need guidance when self-testing (OR = 1.64, 95% CI:
1.03–2.61; OR = 1.06, 95% CI: 1.03–1.08, respectively)
while those with more gender-equitable scores had signif-
icantly lower odds of needing guidance (OR = 0.93, 95%
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Table 1 Description of the participants overall and by test selected
Characteristics Total, n (%) Refused HIV
testing, n (%)
Chose provider-
administered blood
test, n (%)
Chose self-
administered oral
test, n (%)
X2
statistic,
unless
otherwise
specified
P-value
Total 149 (100) 30 (20.13) 35 (23.49) 84 (56.38) NA
Demographics
Age in years 0.086* 0.958*
Mean (SD) 37.07 (7.79) 36.63 (7.49) 36.63 (7.44) 37.40 (8.10)
Median (range) 37.00 (24-62) 35.00 (26-56) 37.00 (25-57) 36.50 (24-62)
High school graduate 0.149 0.928
No 92 (61.74) 18 (19.57) 21 (22.82) 53 (57.61)
Yes 57 (38.26) 12 (21.05) 14 (24.56) 31 (54.39)
Mean income from truck
driving job per month
(Kenyan Shillings)
2.565 0.277
8000–23,999 KES 34 (24.46) 4 (11.77) 9 (26.47) 21 (61.76)
24,000–55,000 KES 105 (75.54) 26 (24.76) 24 (22.86) 55 (52.38)
Married (legal or
common-law)
NA 0.526**
No 25 (17.01) 5 (20.00) 8 (32.00) 12 (48.00)
Yes 122 (82.99) 24 (19.67) 27 (22.13) 71 (58.20)
Risk behavior
Has other regular
partner(s) on the
trucking route
3.028 0.220
No 76 (51.70) 19 (25.00) 19(25.00) 38 (50.00)
Yes 71 (48.30) 11 (15.49) 15 (21.13) 45 (63.38)
Paid for sex in past
6 months
3.851 0.146
No 66 (47.14) 17 (25.76) 16 (24.24) 33 (50.00)
Yes 74 (52.86) 10 (13.52) 17 (22.97) 47 (63.51)
Always used condoms
when had sex in the past
6 months
NA 0.292**
No 122 (84.72) 26 (21.31) 25 (20.49) 71 (58.20)
Yes 22 (15.26) 4 (18.18) 8 (36.38) 10 (45.46)
Drank alcohol in past year 6.296 0.043
No 72 (48.32) 18 (25.00) 21 (29.17) 33 (45.83)
Yes 77 (51.68) 12 (15.59) 14 (18.18) 51 (66.23)
Ever tested for HIV before NA 0.278**
No 15 (10.07) 5 (33.33) 4 (26.67) 6 (40.00)
Yes 134 (89.93) 25 (18.66) 31 (23.13) 78 (58.21)
Number of years since last
HIV test among those
ever tested (those never
tested assigned age)
2.161* 0.339*
Mean (SD) 4.74 (11.38) 6.07 (12.45) 5.41 (10.87) 3.98 (11.25)
Median (range) 0.67 (0.1–59.0) 0.42 (0.08–42.92) 0.46 (0.08–39.00) 0.75 (0.08–59.00)
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CI: 0.88–0.99). In the adjusted model including all pre-
dictors, those with higher fatalism scores had higher odds
of needing guidance (OR = 1.10, 95% CI: 1.03–1.17),
while those with regular partners along the trucking route
(road wives) had significantly lower odds of needing
guidance (OR = 0.10, 95% CI: 0.01–1.00). In the final
stepwise model, those with higher fatalism scores had
significantly higher odds of needing guidance (OR = 1.07,
95% CI: 1.03–1.11). Those having regular partners along
the trucking route (OR = 0.25, 95% CI: 0.06–1.00) had
lower odds of needing guidance of borderline statistical
significance, while being a high school graduate
(OR = 2.93, 95% CI: 0.85–10.10) was associated with
higher odds of needing guidance at borderline statistical
significance. (Table 4).
Discussion
The majority of participants offered HIV testing choices
chose the self-administered oral HIV test (56.38 vs.
23.49% who chose the provider-administered test and
20.13% who refused testing). Thus, the self-administered
oral HIV test was acceptable to many. However, some
participants still chose the standard blood-based provider-
administered HIV test, suggesting that people differ in their
Table 1 continued
Characteristics Total, n (%) Refused HIV
testing, n (%)
Chose provider-
administered blood
test, n (%)
Chose self-
administered oral
test, n (%)
X2
statistic,
unless
otherwise
specified
P-value
Attitudinal scales
Anticipated HIV stigma,
higher score-more
stigma (Cronbach’s
alpha = 0.80)
4.308* 0.116*
Mean (SD) 0.80 (1.53) 0.97 (1.52) 1.03 (1.62) 0.64 (1.51)
Median (range) 0.00 (0.0–9.00) 0.00 (0.00–6.00) 0.00 (0.00–6.00) 0.00 (0.00–9.00)
Fatalism, higher
score = more fatalistic
(Cronbach’s
alpha = 0.94)
5.745* 0.052*
Mean (SD) 46.62 (21.58) 44.17 (17.16) 54.57 (22.38) 44.18 (22.08)
Median (range) 46.00 (20.00–97.00) 42.50 (20.00–93.00) 54.00 (20.00–97.00) 44.00 (20.00–92.00)
General self-efficacy,
higher score higher
efficacy (Cronbach’s
alpha = 0.90)
1.571* 0.456*
Mean (SD) 36.64 (4.40) 36.90 (3.22) 37.57 (3.84) 36.16 (4.92)
Median (range) 39.00 (25.00–40.00) 37.00 (29.00–40.00) 39.00 (26.00–40.00) 39.00 (25.00–40.00)
Gender-equity, higher
score-more gender-
equity attitudes
(Cronbach’s
alpha = 0.88)
4.841* 0.089*
Mean (SD) 58.36 (9.46) 60.60 (10.63) 56.20 (9.02) 58.46 (9.00)
Median (range) 59.00 (34.00–72.00) 63.00 (34.00–72.00) 57.00 (35.00–72.00) 58.50 (38.00–72.00)
Sensation-seeking, higher
score = more sensation-
seeking (Cronbach’s
alpha = 0.73)
4.497* 0.106*
Mean (SD) 1.38 (0.60) 1.18 (0.33) 1.32 (0.52) 1.48 (0.69)
Median (range) 1.00 (1.00–3.00) 1.00 (1.00–2.00) 1.00 (1.00–2.50) 1.00 (1.00–3.00)
* Kruskal–Wallis Test
** Fishers exact test conducted in SAS 9.3 (Cary, NC)
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testing preferences and choices are important so more
people can find an option that works for them, as has been
previously suggested [50].
When the truck drivers in this study self-administered
the oral HIV test, the majority did so correctly without
needing guidance (52.38%). However, a high proportion
did ask questions during the process (47.61%) but by being
allowed to ask questions, very few required unsolicited
correction by the HTC (13.10%). In fact, all of those who
needed unsolicited correction at some point in the testing
Table 2 Logistic regression models looking at predictors of selecting the self-administered oral HIV test (versus the provider-administered
blood test) among those who tested
Crude models Adjusted model (n = 98) Likelihood ratio
backward stepwise
regression with p\ 0.2
for remaining in the
model) (n = 98)
Variable Number OR (95% CI) P-
value
OR (95% CI) P-value OR (95% CI) P-
value
Age (years) 119 1.01 (0.96–1.07) 0.624 0.97 (0.90–1.1) 0.488
High school graduate 119 0.88 (0.39–1.97) 0.751 0.74 (0.24–2.27) 0.601
Income C24,000 KES/month from truck
driving
109 0.98 (0.39–2.46) 0.969 1.23 (0.34–4.41) 0.748
Married 118 1.75 (0.65–4.76) 0.270 0.49 (0.05–5.15) 0.551
Have regular partners on trucking route in
past 6 months (road wife)
117 1.50 (0.67–3.35) 0.322 1.66 (0.48–5.70) 0.421
Paid for sex in past 6 months 113 1.34 (0.59–3.03) 0.481 0.78 (0.21–3.00) 0.731
Always use condoms 114 0.44 (0.16–1.24) 0.120 0.16 (0.02–1.42) 0.100 0.34 (0.10–1.14) 0.081
Drank alcohol in past year 119 2.32 (1.04–5.19) 0.041 1.42 (0.49–4.14) 0.523
Ever tested for HIV 119 1.68 (0.44–6.35) 0.447 NA NA
Years since tested for HIV 116 0.99 (0.96–1.02) 0.531 1.0 (0.98–1.07) 0.322
Anticipated HIV stigma 119 0.86 (0.68–1.10) 0.224 0.80 (0.53–1.21) 0.289
Fatalism 119 0.98 (0.96–0.99) 0.024 0.96 (0.93–0.0.99) 0.030 0.97 (0.94–0.99) 0.003
General self-efficacy 119 0.93 (0.84–1.02) 0.135 0.86 (0.73–1.03) 0.077 0.83 (0.73–0.95) 0.008
Gender-equity 119 1.03 (0.98–1.07) 0.214 0.98 (0.90–1.07) 0.692
Sensation-seeking 119 1.52 (0.78–2.98) 0.219 1.38 (0.47–4.12) 0.560
Table 3 Steps in the self-testing process where participants needed guidance (asked questions or unsolicited correction from the provider)
(n = 84)
Did correctly without asking
questions or needing correction
Did correctly but
asked questions
Needed unsolicited correction by the
provider to do correctly
Totala 44 (52.38%) 40 (47.62%) 11 (13.10%)
Looked at instructions provided 60 (73.17%) 22 (26.83%) 0 (0.00%)
Opened package and removed materials (3
missing)
54 (66.67%) 25 (30.86%) 2 (2.47%)
Removed cap on test tube (3 missing) 56 (69.14%) 24 (29.63%) 1 (1.23%)
Placed test tub in holder (3 missing) 58 (71.60%) 22 (27.16%) 1 (1.24%)
Located and removed the testing swab
without touching it (missing 6)
52 (66.67%) 24 (30.77%) 2 (2.56%)
Collected oral sample (3 missing) 55 (67.90%) 23 (28.40%) 3 (3.70%)
Inserted swab into test tube (3 missing) 55 (67.90%) 24 (29.63%) 2 (2.47%)
Waited 20 min before reviewing for
results (3 missing)
51 (62.96%) 25 (30.87%) 5 (6.17%)
Interpreted test correctly (4 missing) 52 (65.00%) 24 (30.00%) 4 (5.00%)
a All those who needed unsolicited correction also asked questions so the total is[84
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process also asked questions at other points during the
process, indicating that they knew they needed guidance to
administer the test correctly, even if at some points when
they needed guidance they did not request it while at other
points they did. Thus it seems that, for the most part,
people know when they do not understand the instructions
and, if given an opportunity to ask questions to obtain
clarification, most will be able to administer the test cor-
rectly. Therefore, it is important to have some mechanism
for people to be able to ask questions while self-testing,
especially that first time. This could be a phone hotline for
populations who have access to phones, such as truck
drivers, or offering supervised self-testing the first time
someone tests him or herself.
The steps in the self-testing process where more par-
ticipants asked questions or required unsolicited instruction
included not contaminating the swab by touching it and
waiting the necessary amount of time before looking at the
test result. These issues have been reported in another study
in Kenya where people were videotaped while self-ad-
ministering the test [23], and therefore, the instructions for
these steps need to be clarified or better emphasized. The
issue of waiting time, in particular, needs better clarifica-
tion, as some people may not have access to a dependable
clock and, as found in our study, even those who do have
such access may not monitor the time accurately. The fairly
high proportion of participants who asked questions or
required correction when interpreting the test results may
be attributed in part to the fact that all the tests in this study
were negative. Participants may have identified the nega-
tive result but leaned toward concluding that it was positive
or inconclusive in the hope of receiving correction, which
might be a stronger confirmation of a negative test than just
having their reading of a negative test confirmed. This
coping mechanism of expecting the worst even when it is
unlikely has been described before [51].
Almost all of the participants who self-tested chose to
view their test results with the HTC counselor. Of the two
participants who opted to view their results alone, both
disclosed the test result to the counselor during posttest
counseling. This is important as one concern about self-
testing is that people will not disclose their status and thus
will not get appropriate counseling, referrals and linkage to
HIV care. However, all participants who self-tested in this
study tested HIV-negative and whether those who test
HIV-positive who view their test results in private will also
disclose that result during posttest counseling is unknown.
We found very few significant predictors of HIV test
selection when offered HIV testing choices. None of the
demographic variables differed among test refusers versus
test accepters (either test), nor did they differ by the test
selected (self- versus provider-administered) among those
who did test. There were also few significant differences in
testing or in the test selected among testers by HIV-related
Table 4 Logistic regression models looking at predictors of needing guidance (asking questions) when self-testing
Crude models Adjusted model (n = 69) Likelihood ratio backward
stepwise regression with
p\ 0.2 for remaining in the
model) (n = 69)
Variable Number OR (95% CI) P-
value
OR (95% CI) P-value OR (95% CI) P-value
Age (years) 84 1.00 (0.95–1.05) 0.996 0.95 (0.85–1.05) 0.348
High school graduate 84 1.58 (0.65–3.86) 0.312 2.05 (0.48–8.89) 0.336 2.93 (0.85–10.10) 0.089
Income C24,000 KES/month from
truck driving
76 0.55 (0.20–1.54) 0.257 1.17 (0.26–5.38) 0.837
Married 83 1.94 (0.53–7.04) 0.311 0.95 (0.05–18.01) 0.970)
Have regular partners on trucking
route in past 6 months (road wife)
83 0.89 (0.37–2.08) 0.762 0.10 (0.01–0.99) 0.049 0.25 (0.06–1.00) 0.050
Paid for sex in past 6 months 80 1.15 (0.47–2.81) 0.759 4.05 (0.40–31.19) 0.238
Always use condoms 81 0.42 (0.10–1.74) 0.230 0.42 (0.02–8.83) 0.580
Drank alcohol in past year 84 0.52 (0.21–1.25) 0.144 0.79 (0.19–3.34) 0.747
Ever tested for HIV 84 0.16 (0.02–1.46) 0.105 NA NA NA NA
Years since tested for HIV 82 1.04 (0.99–1.09) 0.167 1.03 (0.95–1.11) 0.541
Anticipated HIV stigma 84 1.64 (1.03–2.61) 0.039 1.34 (0.72–2.49) 0.356
Fatalism 84 1.06 (1.03–1.08) \0.001 1.10 (1.03–1.17) 0.005 1.07 (1.03–1.11) \0.001
General self-efficacy 84 0.92 (0.84–1.01) 0.085 1.14 (0.89–1.47) 0.341
Gender-equity 84 0.93 (0.88–0.98) 0.011 1.07 (0.96–1.20) 0.237
Sensation-seeking 84 1.72 (0.90–3.28) 0.102 1.76 (0.37–8.34) 0.476
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behaviors. Those who drank alcohol were significantly less
likely to refuse HIV testing than to accept either testing
choice, and among those who tested, drinkers were more
likely to choose the self-administered test, but this asso-
ciation disappeared after adjusting for covariates. There
were a few significant associations between test selected
and psychosocial measures. Truck drivers have been
described as having fatalistic views [7, 8], and it has been
suggested that fatalism might be a barrier to HIV testing
[52]. However, we found that fatalism scores were actually
lowest among those who refused HIV testing compared to
those who selected either the provider- or the self-admin-
istered HIV test, although the association was of borderline
significance (p = 0.052). Among those who tested, higher
fatalism scores were associated with significantly lower
odds of choosing the self-administered oral HIV test over
the provider-administered blood test in all regression
models. This association was as we expected; as fatalism
might impact concerns about severe reactions to the test
result, we would expect that those with more fatalistic
views would see more potential benefits for the provider-
administered test rather than the self-administered test. The
fact that the test refusers had lower fatalism scores than
those who chose the self- or provider-administered test in
the descriptive analysis might be due to the changing nat-
ure of the questions posed—from ‘‘would you like an HIV
test?’’ to ‘‘which HIV test would you prefer?’’ When posed
in terms of test preference rather than testing at all, those
with more fatalistic views might have an easier time
accepting one of the testing choices presented rather than
actively refusing testing all together. It could also be that
some of those who refused HIV testing did so because they
wanted to test elsewhere, perhaps with a partner, which
was a sentiment expressed by a number of study partici-
pants. Thus, some test refusers might be less fatalistic but
have preferences for a different form of testing than what
was offered in this study.
We were surprised to find that those with higher self-
efficacy scores were less likely to choose the self-admin-
istered HIV test among those who tested. This association
was only significant in the stepwise model, but was of
borderline significance in the other models. We had
expected that those with higher self-efficacy would be
more likely to choose a test that they administer themselves
rather than having someone else administer the test. A
previous study in Malawi found self-efficacy to be posi-
tively associated with HIV testing in general [35], so again
self-efficacy may have a different impact on test selection
when given testing choices than when offered testing in a
way that elicits a yes or no response. Also, it is important to
note that our participants were recruited from a general
healthcare clinic, although not necessarily there for HIV
testing, and the impact of self-efficacy on HIV testing may
be, in part, related to going to a clinic specifically for
testing as opposed to accepting testing when offered after
arrival at a clinic.
Although the sample was small (n = 69), we explored
predictors of needing guidance while self-testing. The only
significant association we found was that those with more
fatalistic views had significantly higher odds of needing
guidance and this association was consistent across all
models (crude, multivariate and stepwise). This may be
consistent with the idea that those who are more fatalistic
have less faith that they have control over correctly
administering the test and therefore seek guidance and
affirmation that they are doing it correctly.
This study has a number of limitations. First, the number
of participants included in these analyses was small
(n = 149) and therefore we may not have had sufficient
statistical power to identify some associations. The results
presented here are for secondary research questions and the
study was not powered specifically for these analyses. The
lack of power was further exacerbated by the large number
of variables we examined and when looking at a subset of
the participants (e.g., the 69 who self-tested). We used
backward stepwise regression as a way to try to reduce the
number of variables in the model in the event that some
were not significant in the full multivariate model due to
over saturation. In addition, because of the number of
variables examined, some associations found may have
been spurious associations (i.e., type 1 errors). As all the
independent variables were based on self-report, there may
have been some misclassification due to recall error, social
desirability bias or simply misunderstanding of the ques-
tions. The psychosocial scales administered have not been
validated in Kenya and were new kinds of questions for our
fieldworkers as well as for the participants and there may
have been some discomfort or confusion in answering
questions that were not obviously related to HIV, which
may have impacted the quality of the responses. However,
all of the scales demonstrated good internal consistency
and a few were predictive of the outcomes examined,
although not always in the direction expected. In addition,
as study participants were recruited from clinics, our
sample may not have been representative of truck drivers in
Kenya or elsewhere, many of whom may not access clinics
for healthcare services. Therefore, generalization of the
results should be made with caution.
Conclusions
Despite these limitations, our findings suggest that self-
administered oral HIV testing was acceptable among this
sample of Kenyan truck drivers and that when given the
opportunity to ask questions, the vast majority (86.90%)
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were able to administer the test and interpret the results
correctly themselves on the first try, and more than half of
those who self-tested did so correctly without soliciting any
guidance. Supervised self-testing, at least the first time
someone uses the self-administered test, might be a good
option to ensure correct use and provide the opportunity for
asking questions. We did not find any differences in the
HIV test chosen by demographic characteristics or HIV-
related behavior. However, we did find an association
between having more fatalistic views and lower odds of
choosing the self-administered HIV test as well as higher
odds of needing guidance when self-administering the test.
This finding may warrant additional research into the
impact fatalism plays on HIV testing behavior and what
kinds of interventions can reduce fatalistic ideas around
HIV and HIV testing, especially given the fact that truck
drivers are viewed as being fairly fatalistic in their outlook
[7, 8].
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